3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
20
Polycystic Ovary Syndrome
6
Infertility
4
Neoplasm Metastasis
2
Leiomyoma
2
is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients.
1
Patient Acceptance of Health Care
1
Ovarian Cysts
1
Myofibroma
1
Locally Advanced Breast Cancer
1
Infertility, Female
1
Carcinoma, Ductal
1
Breast Neoplasm Malignant Female
1
Breast Carcinoma In Situ
1
Anovulation
1
Abortion, Spontaneous
1
Interventions
Letrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Breast Neoplasm Malignant Female
×
Letrozole
×
Clear all
NCT04289805
2025-01-31
fAMHOPE
Erasme University Hospital
Phase 4
Terminated
96 enrolled